12:00 AM
 | 
Nov 03, 2003
 |  BioCentury  |  Finance

EPS Mixed grill

EPS Mixed grill

Company 3Q EPS est 3Q EPS actual Outcome Growth from 3Q02 10/31 cls Wk chg % chg Mkt cap chg ($M) 10/31 mkt cap ($M)
Actelion (SWX:ATLN) NA CHF0.65 NA NA CHF127 CHF7.5 6% CHF167.3 ($127.6) CHF2832 ($2,160)
No consensus estimate, and company posted a loss in 3Q02. 3Q03 sales of Tracleer bosentan to treat pulmonary arterial hypertension grew 19% to CHF80.3M. For 2003, ATLN said it is on track to post operating revenues of CHF290-CHF310M ($221-$236M) (see Product Development, A13).
Aventis (AVE) NA E0.82

Read the full 684 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >